Vaxil Bio Ltd.
NYSE
Vaxil Bio Ltd.'s latest marketcap:
As of 05/23/2025, Vaxil Bio Ltd.'s market capitalization has reached $534,800.37. According to our data, Vaxil Bio Ltd. is the 48253th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 534,800.37 |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -128,695.78 |
| Shares Out | 2.74 M |
| EPS (ttm) | -0.05 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/27/2025 |
Vaxil Bio Ltd.'s yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/05/2025 | C$808,176 | -41% |
| 05/22/2024 | C$1.37 M | -60% |
| 12/29/2023 | C$3.42 M | 25% |
| 12/30/2022 | C$2.74 M | -73.33% |
| 12/31/2021 | C$10.27 M | -70.43% |
| 12/31/2020 | C$34.74 M |
Company Profile
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.
The company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma.
It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidate. The company was founded in 2006 and is headquartered in Toronto, Canada.
Frequently Asked Questions
-
What is Vaxil Bio Ltd.'s (TSXV-VXL) current market cap?As of 05/23/2025, Vaxil Bio Ltd. (including the parent company, if applicable) has an estimated market capitalization of $534,800.37 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Vaxil Bio Ltd. (TSXV-VXL) rank globally by market cap?Vaxil Bio Ltd. global market capitalization ranking is approximately 48253 as of 05/23/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.